Artículos de revistas sobre el tema "Adjuvant 5-Fluorouracil"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Adjuvant 5-Fluorouracil".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Nimeiri, Halla Sayed, Yang Feng, Paul J. Catalano, Neal J. Meropol, Bruce J. Giantonio, Elin R. Sigurdson, James A. Martenson et al. "Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil, and leucovorin versus oxaliplatin, 5-fluorouracil, and leucovorin versus 5-fluorouracil and leucovorin for patients with stage II or III rectal cancer receiving either preoperative radiation and 5-fluorouracil or postoperative radiation and 5-fluorouracil: ECOG E3201—An updated survival analysis." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e14711-e14711. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e14711.
Texto completoAsaria, Riaz Hassan Yusuf, Chee Hing Kon, Catey Bunce, David G. Charteris, David Wong, Peng Tee Khaw y George William Aylward. "Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy". Ophthalmology 108, n.º 7 (julio de 2001): 1179–83. http://dx.doi.org/10.1016/s0161-6420(01)00589-9.
Texto completoAmonkar, Sunil J., Henry J. Cain, Tracey Hughes, J. Diane Hemming y David A. Browell. "Adjuvant 5-Fluorouracil-Induced Colitis Necessitating Completion Colectomy". Journal of Gastrointestinal Cancer 42, n.º 4 (6 de enero de 2011): 275–77. http://dx.doi.org/10.1007/s12029-010-9241-1.
Texto completoHill, GeorgeJ, L. Peter Fielding, Rosemary Hittinger, RogerH Grace y JohnS Fry. "Adjuvant treatment with 5-fluorouracil for colorectal cancer". Lancet 340, n.º 8831 (noviembre de 1992): 1349–50. http://dx.doi.org/10.1016/0140-6736(92)92530-s.
Texto completoKizilbash, Sani Haider, Kevin Ward, Ishmael A. Jaiyesimi y Joseph Lipscomb. "Survival outcomes in patients with early-stage, resectable pancreatic cancer: A comparison of gemcitabine and 5-fluorouracil based chemotherapy and chemoradiation regimens." Journal of Clinical Oncology 30, n.º 15_suppl (20 de mayo de 2012): e14608-e14608. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e14608.
Texto completoKelder, Wendy, Geke A. P. Hospers y John T. M. Plukker. "Effects of 5-fluorouracil adjuvant treatment of colon cancer". Expert Review of Anticancer Therapy 6, n.º 5 (mayo de 2006): 785–94. http://dx.doi.org/10.1586/14737140.6.5.785.
Texto completoVaillant, Jean-Christophe, Bernard Nordlinger, Sylvie Deuffic, Jean-Pierre Arnaud, Edouard Pelissier, Jean-Pierre Favre, Daniel Jaeck et al. "Adjuvant Intraperitoneal 5-Fluorouracil in High-Risk Colon Cancer". Annals of Surgery 231, n.º 4 (abril de 2000): 449–56. http://dx.doi.org/10.1097/00000658-200004000-00001.
Texto completoMerendino, R. A., A. Ruello, S. Cascinu, B. Ferlazzo, A. Bene, D. Bonanno, P. Quattrocchi, N. Caristi y S. Gangemi. "Influence of 5-Fluorouracil and Folinic Acid on Interleukin-18 Production in Colorectal Cancer Patients". International Journal of Biological Markers 17, n.º 1 (enero de 2002): 63–66. http://dx.doi.org/10.1177/172460080201700108.
Texto completoDencausse, Y., G. Hartung, J. Sturm, A. Kopp-Schneider, E. Hagmüller, C. Wojatschek, H. Lindemann, D. Fritze y W. Queisser. "Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin". Oncology Research and Treatment 25, n.º 5 (2002): 426–30. http://dx.doi.org/10.1159/000067436.
Texto completoBertuccelli, Maurizio, Francesco Cartei, Alfredo Falcone, Salvatrice Campoccia, Aldo Sainato, Francesco Ducci, Stefano Moda et al. "Postoperative Adjuvant Chemoradiotherapy for Rectal Cancer: Analysis of Acute and Chronic Toxicity". Tumori Journal 83, n.º 2 (marzo de 1997): 599–603. http://dx.doi.org/10.1177/030089169708300224.
Texto completoChao, Michael WT, David Byram, Richard Bell, Rodney Bond, Steven Vaughan, Roger McLennan, Michael Lim-Joon, Morikatsu Wada y David Joseph. "Postoperative adjuvant radiotherapy and 5-fluorouracil chemotherapy for rectal carcinoma". Australasian Radiology 42, n.º 1 (febrero de 1998): 47–51. http://dx.doi.org/10.1111/j.1440-1673.1998.tb00564.x.
Texto completoBatey, M. A., J. G. Wright, A. Azzabi, D. R. Newell, M. J. Lind, A. H. Calvert y A. V. Boddy. "Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF)". European Journal of Cancer 38, n.º 8 (mayo de 2002): 1081–89. http://dx.doi.org/10.1016/s0959-8049(02)00024-2.
Texto completoSanoff, Hanna K., William R. Carpenter, Janet Freburger, Ling Li, Kun Chen, Leah L. Zullig, Richard M. Goldberg, Maria J. Schymura y Deborah Schrag. "Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer". Cancer 118, n.º 17 (31 de enero de 2012): 4309–20. http://dx.doi.org/10.1002/cncr.27422.
Texto completoStabuc, Borut. "Systemic therapy for colorectal cancer". Archive of Oncology 11, n.º 4 (2003): 255–63. http://dx.doi.org/10.2298/aoo0304255s.
Texto completoShe, Poh Fong, Khairidzan Mohd Kamal, Akmal Haliza Zamli, Norra Harun y Safinaz Mohd Khialdin. "Chemo-adjuvant therapy in recurrent conjunctival intraepithelial neoplasia". Malaysian Journal of Ophthalmology 2, n.º 3 (28 de septiembre de 2020): 232–37. http://dx.doi.org/10.35119/myjo.v2i3.106.
Texto completoDeng, Ke, Haitao Xiao, Xiaoxue Liu, Rei Ogawa, Xuewen Xu y Yong Liu. "Strontium-90 brachytherapy following intralesional triamcinolone and 5-fluorouracil injections for keloid treatment: A randomized controlled trial". PLOS ONE 16, n.º 3 (23 de marzo de 2021): e0248799. http://dx.doi.org/10.1371/journal.pone.0248799.
Texto completoGwak, Geumhee, Kyeongmee Park, Eunah Shin, Sehwan Han, Ji-Young Kim, Hongyong Kim, Young Duk Kim et al. "Comparison of CVF (Cyclophosphamide+Vinorelbine+5-Fluorouracil) and CMF (Cyclophosphamide+Methotrexate+5-Fluorouracil) Adjuvant Chemotherapy in Early Breast Cancer". Journal of Breast Cancer 14, n.º 3 (2011): 223. http://dx.doi.org/10.4048/jbc.2011.14.3.223.
Texto completoOblak, Irena, Marija Skoblar Vidmar, Franc Anderluh, Vaneja Velenik, Ana Jeromen y Jasna But Hadzic. "Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma". Radiology and Oncology 48, n.º 2 (1 de junio de 2014): 189–96. http://dx.doi.org/10.2478/raon-2013-0065.
Texto completoFrancini, Guido, Roberto Petrioli, Luciano Lorenzini, Sergio Mancini, Salvatore Armenio, Gabriello Tanzini, Stefania Marsili et al. "Adjuvant Chemotherapy with Folinic Acid and 5-Fluorouracil in Colon Cancer". Tumori Journal 83, n.º 1_suppl1 (enero de 1997): 38. http://dx.doi.org/10.1177/03008916970831s118.
Texto completoCassidy, J. "Adjuvant 5-fluorouracil plus levamisole in colon cancer: the plot thickens?" British Journal of Cancer 69, n.º 6 (junio de 1994): 986–87. http://dx.doi.org/10.1038/bjc.1994.193.
Texto completoFrancini, Guido, Roberto Petrioli, Luciano Lorenzini, Sergio Mancini, Salvatore Armenio, Gabriello Tanzini, Stefania Marsili et al. "Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer". Gastroenterology 106, n.º 4 (abril de 1994): 899–906. http://dx.doi.org/10.1016/0016-5085(94)90748-x.
Texto completoFrasci, Giuseppe, Francesco Leone, Mario Monaco, Luigi Cremone, Ugo Sapio, Felice Faiella, Angelo Espinosa y Giovanni Persico. "5-fluorouracil-interferon-α2b adjuvant treatment of Dukes C colorectal cancer". Diseases of the Colon & Rectum 37, n.º 7 (julio de 1994): 643–50. http://dx.doi.org/10.1007/bf02054406.
Texto completoJeung, Hei C., Sun Y. Rha, Sung H. Noh, Jin S. Min, Byung S. Kim y Hyun C. Chung. "Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma". Cancer 91, n.º 11 (2001): 2016–25. http://dx.doi.org/10.1002/1097-0142(20010601)91:11<2016::aid-cncr1227>3.0.co;2-i.
Texto completoJha, Abhijeet Kumar y Sidharth Sonthalia. "5-Fluorouracil as an adjuvant therapy along with microneedling in vitiligo". Journal of the American Academy of Dermatology 80, n.º 4 (abril de 2019): e75-e76. http://dx.doi.org/10.1016/j.jaad.2018.12.008.
Texto completoArkenau, H. T., K. Rettig y R. Porschen. "Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion". International Journal of Colorectal Disease 20, n.º 3 (11 de noviembre de 2004): 258–61. http://dx.doi.org/10.1007/s00384-004-0657-6.
Texto completoKatori, Hideaki, Akinori Nozawa y Mamoru Tsukuda. "Post-operative adjuvant chemoradiotherapy with carboplatin and 5-fluorouracil for primary branchiogenic carcinoma". Journal of Laryngology & Otology 119, n.º 6 (junio de 2005): 467–69. http://dx.doi.org/10.1258/0022215054273241.
Texto completovan Hellemond, Irene E. G., Annemarie M. Thijs y Geert-Jan Creemers. "Capecitabine-Associated Terminal Ileitis". Case Reports in Oncology 11, n.º 3 (22 de octubre de 2018): 654–59. http://dx.doi.org/10.1159/000492781.
Texto completoLim, Stephanie Hui-Su, Sharon Mary Wilson, Arnagretta Hunter, Jane Hill y Philip Beale. "Takotsubo Cardiomyopathy and 5-Fluorouracil: Getting to the Heart of the Matter". Case Reports in Oncological Medicine 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/206765.
Texto completoZhang, J., J. Xiang, Y. Zhang y X. Zhou. "Adjuvant chemotherapy of cisplatin, 5-fluorouracil (5-FU) plus leucovorin (LV) for esophageal cancer: A case-matched cohort study in east china". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 15135. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15135.
Texto completoMendoza-Rodríguez, Mónica G., C. Ángel Sánchez-Barrera, Blanca E. Callejas, Verónica García-Castillo, Diana L. Beristain-Terrazas, Norma L. Delgado-Buenrostro, Yolanda I. Chirino et al. "Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis". International Journal of Molecular Sciences 21, n.º 6 (20 de marzo de 2020): 2130. http://dx.doi.org/10.3390/ijms21062130.
Texto completoCascinu, Stefano, Gabriele Valentini y Giuseppina Catalano. "A Pilot Clinical Trial of Postoperative Adjuvant Intraperitoneal Cisplatin, 5-Fluorouracil, 6S-Leucovorin and Interferon Alpha 2b in Patients with Resected Gastric Cancer". Tumori Journal 79, n.º 5 (octubre de 1993): 331–35. http://dx.doi.org/10.1177/030089169307900509.
Texto completoCremona, F., F. Izzo, F. Ruffolo, R. Palaia y V. Parisi. "Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion". Journal of Chemotherapy 9, n.º 2 (enero de 1997): 140–41. http://dx.doi.org/10.1179/joc.1997.9.2.140.
Texto completoRudkin, A. K. y J. S. Muecke. "Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia". British Journal of Ophthalmology 95, n.º 7 (20 de enero de 2011): 947–50. http://dx.doi.org/10.1136/bjo.2010.186171.
Texto completoPaulino, Arnold C. "Resected Pancreatic Cancer Treated With Adjuvant Radiotherapy With or Without 5-Fluorouracil". American Journal of Clinical Oncology: Cancer Clinical Trials 22, n.º 5 (octubre de 1999): 489. http://dx.doi.org/10.1097/00000421-199910000-00014.
Texto completoÖsterlund, Pia, Tarja Ruotsalainen, Katri Peuhkuri, Riitta Korpela, Anneli Ollus, Minna Ikonen, Heikki Joensuu y Inkeri Elomaa. "Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer". Clinical Gastroenterology and Hepatology 2, n.º 8 (agosto de 2004): 696–703. http://dx.doi.org/10.1016/s1542-3565(04)00293-9.
Texto completoJohnson, Jonas T., Eugene N. Myers, David G. Mayernik, Teresa A. Nolan, Barbara A. Sigler y Robin L. Wagner. "Adjuvant Methotrexate???5-Fluorouracil for Extracapsular Squamous Cell Carcinoma in Cervical Metastasis". Laryngoscope 100, n.º 6 (junio de 1990): 590???592. http://dx.doi.org/10.1288/00005537-199006000-00007.
Texto completoJamieson, David, Jo Lee, Nicola Cresti, Rosanna Jackson, Melanie Griffin, Julieanne Sludden, Mark Verrill y Alan V. Boddy. "Pharmacogenetics of adjuvant breast cancer treatment with cyclophosphamide, epirubicin and 5-fluorouracil". Cancer Chemotherapy and Pharmacology 74, n.º 4 (24 de julio de 2014): 667–74. http://dx.doi.org/10.1007/s00280-014-2541-6.
Texto completoKulig, J., T. Popiela, P. Richter y S. Klek. "Evaluation of Adjuvant Chemotherapy Irinotecan + 5-Fluorouracil + Leucovorine in Advanced Colorectal Cancer". Acta Chirurgica Belgica 107, n.º 3 (enero de 2007): 297–301. http://dx.doi.org/10.1080/00015458.2007.11680060.
Texto completoSUZUKI, TAKANORI, SUSUMU JINBO, MASAYA MIKI, SHIGEKI INABA, TOSHIHIRO SHIMIZU, TOORU MASHIMO, KYOICHI IMAI, HIDETOSHI YAMANAKA y JUN KOYA. "ADJUVANT CHEMOTHERAPY OF CIS-DIAMMINEDICHLOROPLATINUM, ADRIAMYCIN AND 5-FLUOROURACIL FOR UROTHELIAL CANCERS". KITAKANTO Medical Journal 37, n.º 5 (1987): 453–58. http://dx.doi.org/10.2974/kmj1951.37.453.
Texto completoMustafa, Syed Arshad, M. Ismail, Saquib Zaffar, Ghulam Hassan, Waseem Qureshi y SM Kadri. "Outcome of Adjuvant Concurrent Chemo-Radiation in Operated Locally Advanced Rectal Cancer". Journal of Enam Medical College 5, n.º 3 (10 de noviembre de 2015): 139–44. http://dx.doi.org/10.3329/jemc.v5i3.24744.
Texto completoAhn, Joong B., Kwang Y. Shim, Hei C. Jeung, Sun Y. Rha, Nae C. Yoo, Nam K. Kim, Jae K. Roh, Jin S. Min, Byung S. Kim y Hyun C. Chung. "Monthly 5-days 5-fluorouracil and low-dose leucovorin for adjuvant chemotherapy in colon cancer". Cancer Letters 167, n.º 2 (junio de 2001): 215–24. http://dx.doi.org/10.1016/s0304-3835(01)00485-2.
Texto completoEdler, David, Bengt Glimelius, Marja Hallström, Anders Jakobsen, Patrick G. Johnston, Inger Magnusson, Peter Ragnhammar y Henric Blomgren. "Thymidylate Synthase Expression in Colorectal Cancer: A Prognostic and Predictive Marker of Benefit From Adjuvant Fluorouracil-Based Chemotherapy". Journal of Clinical Oncology 20, n.º 7 (1 de abril de 2002): 1721–28. http://dx.doi.org/10.1200/jco.2002.07.039.
Texto completoLara-Sotelo, Galia, Lorenza Díaz, Rocío García-Becerra, Euclides Avila, Heriberto Prado-Garcia, Gabriela Morales-Guadarrama, María de Jesús Ibarra-Sánchez, José Esparza-López, Fernando Larrea y Janice García-Quiroz. "α-Mangostin Synergizes the Antineoplastic Effects of 5-Fluorouracil Allowing a Significant Dose Reduction in Breast Cancer Cells". Processes 9, n.º 3 (3 de marzo de 2021): 458. http://dx.doi.org/10.3390/pr9030458.
Texto completoMazzotta, Marco, Laura Pizzuti, Eriseld Krasniqi, Francesca Sofia Di Lisa, Federico Cappuzzo, Lorenza Landi, Domenico Sergi et al. "Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?" Cancers 13, n.º 16 (12 de agosto de 2021): 4061. http://dx.doi.org/10.3390/cancers13164061.
Texto completoRon, Ilan G., Nely Wigler, Riva Borovik, George Brufman, Shulamith Rizel, Adi Shani, Joseph Brenner et al. "CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer". American Journal of Clinical Oncology 24, n.º 4 (agosto de 2001): 323–27. http://dx.doi.org/10.1097/00000421-200108000-00001.
Texto completoRon, Ilan G., Nely Wigler, Riva Borovik, Tamar Peretz, Shulamith Rizel, Adi Shani, Joseph Brenner et al. "CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer". American Journal of Clinical Oncology 25, n.º 5 (octubre de 2002): 520–22. http://dx.doi.org/10.1097/00000421-200210000-00020.
Texto completoSobrero, A., G. Frassineti, A. Falcone, L. Dogliotti, R. Rosso, F. D. Costanzo y P. Bruzzi. "Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer". British Journal of Cancer 92, n.º 1 (21 de diciembre de 2004): 24–29. http://dx.doi.org/10.1038/sj.bjc.6602276.
Texto completoDogan, U., H. Abali, F. Ozmen, B. Oksuzoglu, N. Aslan, N. Ozdemir, B. Budakoglu, T. Guler, M. Tumoz y N. Zengin. "6522 Adjuvant chemoradiotherapy with continious infusion 5-fluorouracil and bi-weekly cisplatin and infusional 5-fluorouracil for operated locally advanced gastric cancer". European Journal of Cancer Supplements 7, n.º 2 (septiembre de 2009): 368. http://dx.doi.org/10.1016/s1359-6349(09)71244-3.
Texto completoMoertel, C. G., T. R. Fleming, J. S. Macdonald, D. G. Haller y J. A. Laurie. "Hepatic toxicity associated with fluorouracil plus levamisole adjuvant therapy." Journal of Clinical Oncology 11, n.º 12 (diciembre de 1993): 2386–90. http://dx.doi.org/10.1200/jco.1993.11.12.2386.
Texto completoYakir, Rottenberg, Kadouri Luna, Wygoda Marc, Sella Tamar, Rivkind Avraham y Hubert Ayala. "The Toxicity and Outcomes of Continuous 5-fluorouracil/Cisplatin-based Chemotherapy Followed by Chemoradiation in Patients with Resected High-risk Gastric Cancer: Results of a Single Institute". Annals of the Academy of Medicine, Singapore 37, n.º 3 (15 de marzo de 2008): 200–203. http://dx.doi.org/10.47102/annals-acadmedsg.v37n3p200.
Texto completo